Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Real Life (T-ACI): A Prospective Single-Center Observational Study

Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Real Life (T-ACI): A Prospective Single-Center Observational Study

<b>Background:</b> Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) poses significant challenges in healthcare due to its multidrug resistance and high mortality rates among critically ill patients. <b>Results:</b> We enrolled 45 patients. Cefiderocol wa...

Full description

Bibliographic Details
Main Authors: Antonio Riccardo Buonomo, Riccardo Scotto, Nunzia Esposito, Giulio Viceconte, Nicola Schiano Moriello, Giulia Zumbo, Ilaria Vecchietti, Amedeo Lanzardo, Carmine Iacovazzo, Francesco Curcio, Emanuela Roscetto, Ivan Gentile
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Antibiotics
Subjects:
<i>Acinetobacter baumannii</i>
CRAB
cefiderocol
colistin
Online Access:https://www.mdpi.com/2079-6382/13/11/1007

Internet

https://www.mdpi.com/2079-6382/13/11/1007

Similar Items